Search Results - "ALTUNDAL, Y"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1
  2. 2

    Targeted radiotherapy enhancement during electronic brachytherapy of accelerated partial breast irradiation (APBI) using controlled release of gold nanoparticles by Cifter, G, Chin, J, Cifter, F, Altundal, Y, Sinha, N, Sajo, E, Ngwa, W

    Published in Physica medica (01-12-2015)
    “…Highlights • We propose to use gold nanoparticles (GNPs) during APBI to provide dose boost. • We propose delivery of GNPs by coating the Xoft balloon…”
    Get full text
    Journal Article
  3. 3

    SU‐E‐T‐302; Customizable Radiotherapy Enhancement (CuRE) for Retinal Diseases Using Nanoparticles by Altundal, Y, Sajo, E, Makrigiorgos, G, Ngwa, W

    Published in Medical Physics (01-06-2013)
    “…Purpose: Employing non‐toxic radiosensitizing gold nanoparticles (GNPs) targeted to disease endothelial cells has been proposed as a new strategy to…”
    Get full text
    Conference Proceeding Journal Article
  4. 4
  5. 5

    WE‐E‐108‐02: Tumor Vasculature Dose‐Painting with FDA Approved Concentrations of Cisplatin, Oxaliplatin, and Carboplatin Nanoparticles During External Beam Radiotherapy by Ngwa, W, Altundal, Y, Sajo, E, Makrigiorgos, G, Berbeco, R

    Published in Medical Physics (01-06-2013)
    “…Purpose: Recent studies have cogently demonstrated major dose enhancement to tumor endothelial cells (EC) when targeted with gold nanoparticles (GNPs) during…”
    Get full text
    Conference Proceeding Journal Article
  6. 6

    Tumor lysis syndrome as a contributory factor to the development of reversible posterior leukoencephalopathy by OZKAN, A, HAKYEMEZ, B, OZKALEMKAS, F, ALI, R, OZKOCAMAN, V, OZCELIK, T, TASKAPILIOGLU, O, ALTUNDAL, Y, TUNALI, A

    Published in Neuroradiology (01-12-2006)
    “…Reversible posterior leukoencephalopathy syndrome (RPLS) is a recently described clinical and radiological entity comprising headache, seizures, altered level…”
    Get full text
    Journal Article
  7. 7
  8. 8

    SU-F-I-02: Comparative Analysis and Constancy Check of Image Quality Parameters for Three Linear Accelerators Per TG 142 Protocol by Altundal, Y, Pokhrel, D, Jiang, H, Badkul, R

    Published in Medical physics (Lancaster) (01-06-2016)
    “…Purpose: To compare image quality parameters and assessing the image stability of three different linear accelerators (linac) for 2D and 3D imaging modalities:…”
    Get full text
    Journal Article
  9. 9

    SU‐E‐T‐352: Effects of Skull Attenuation and Missing Backscatter On Brain Dose in HDR Treatment of the Head with Surface Applicators by Cifter, F, Dhou, S, Altundal, Y, Sajo, E, Lewis, J, Cormack, R

    Published in Medical physics (Lancaster) (01-06-2015)
    “…Purpose: To calculate the effect of lack of backscatter from air and attenuation of bone on dose distributions in brachytherapy surface treatment of head…”
    Get full text
    Journal Article
  10. 10

    SU‐D‐210‐04: Using Radiotherapy Biomaterials to Brand and Track Deadly Cancer Cells by Altundal, Y, Sajo, E, Ngwa, W

    Published in Medical physics (Lancaster) (01-06-2015)
    “…Purpose: Metastasis accounts for over 90% of all cancer associated suffering and death and arguably presents the most formidable challenges in cancer…”
    Get full text
    Journal Article
  11. 11

    SU‐E‐T‐279: Dose Enhancement Effect Due to Cerium Oxide Nanoparticles Employed as Radiation Protectants by Ouyang, Z, Altundal, Y, Sajo, E, Ngwa, W

    Published in Medical physics (Lancaster) (01-06-2015)
    “…Purpose: The goal of radiotherapy is to maximize radiation dose to diseased cells while minimizing radiation damage to normal tissues. In order to minimize…”
    Get full text
    Journal Article
  12. 12

    MO‐FG‐BRA‐04: Leveraging the Abscopal Effect Via New Design Radiotherapy Biomaterials Loaded with Immune Checkpoint Inhibitors by Hao, Y, Cifter, G, Altundal, Y, Sinha, N, Moreau, M, Sajo, E, Makrigiorgos, G, Ngwa, W

    Published in Medical physics (Lancaster) (01-06-2015)
    “…Purpose: Studies show that stereotactic body radiation therapy (SBRT) of a primary tumor in combination with immune checkpoint inhibitors (ICI) could Result in…”
    Get full text
    Journal Article
  13. 13

    WE‐G‐BRE‐03: Dose Painting by Numbers Using Targeted Gold Nanoparticles by Altundal, Y, Sajo, E, Korideck, H, Ngwa, W

    Published in Medical physics (Lancaster) (01-06-2014)
    “…Purpose: Homogeneous dose enhancement in tumor cells of lung cancer patients treated with conventional dose of 60–66 Gy in five fractions is limited due to…”
    Get full text
    Journal Article
  14. 14

    WE‐G‐BRE‐06: New Potential for Enhancing External Beam Radiotherapy for Lung Cancer Using FDA‐Approved Concentrations of Cisplatin Or Carboplatin Nanoparticles Administered Via Inhalation by Hao, Y, Altundal, Y, Sajo, E, Detappe, A, Makrigiorgos, G, Berbeco, R, Ngwa, W

    Published in Medical physics (Lancaster) (01-06-2014)
    “…Purpose: This study investigates, for the first time, the dose enhancement to lung tumors due to cisplatin nanoparticles (CNPs) and carboplatin nanoparticles…”
    Get full text
    Journal Article
  15. 15

    Hydatid disease in acute leukemia: effect of anticancer treatment on echinococcosis by Ali, Ridvan, Ozkalemkas, Fahir, Ozkocaman, Vildan, Ozcelik, Tulay, Akalin, Halis, Ozkan, Atilla, Altundal, Yildiz, Tunali, Ahmet

    Published in Microbes and infection (01-07-2005)
    “…Echinococcosis, also known as hydatid disease or hydatidosis, is a zoonotic illness caused by the larval form of Echinococcus spp. It is highly prevalent in…”
    Get full text
    Journal Article
  16. 16